Skip to content
In deliveryUnited KingdomGoodsFramework agreement£52,447,296

NHS National Generics Pharmaceuticals - Supply Chain Resilience

Awarded to Accord UK Ltd, Amarox Limited, Ascend Laboratories +23 more

NHS England(buyer)

Published
Published 21 January 2026
Deadline
Closed 6 March 2026

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

NHS England awarded a framework agreement for generic pharmaceutical supply chain resilience to 26 suppliers on 30 April 2026, valued at £39.2 million. The framework covers orals and non-parenteral products, and hospital-only products across three regional areas, with call-offs running from September 2026 to May 2028 or September 2027 depending on the product category and region. This procurement addresses previously terminated or unawarded product lines to strengthen supply continuity.

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Lots (2)

  • Lot 1 - CM/PHG/25/5739/01 - Oral (plus non-parenteral) products

    CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months) NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months) LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

    £4,213,176Won by Amarox LimitedWon by Aspire Pharma LimitedWon by Milpharm LimitedWon by Teva UK LimitedWon by Wockhardt UK LimitedWon by Zentiva Pharma UK LimitedWon by Colonis Pharma LtdWon by Crescent Pharma LimitedWon by Day Lewis Medical LtdWon by Ennogen Healthcare International LimitedWon by G.L. Pharma UK LimitedWon by Morningside Pharmaceuticals LtdWon by Northumbria Pharma LimitedWon by Selective Supplies LimitedWon by Cipla (EU) Limited
  • Lot 2 - CM/PHG/25/5739/02 - Hospital only products

    CM/PHG/25/5739/02 – Hospital Only Products DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months) DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months) DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

    £35,010,320Won by Glenmark Pharmaceuticals (Europe) LtdWon by Amarox LimitedWon by Baxter Healthcare LtdWon by Brown and Burk UK LtdWon by Jannsen-Cilag LimitedWon by Accord UK LtdWon by Ascend LaboratoriesWon by Aspire Pharma LimitedWon by Cipla (EU) LimitedWon by Hikma Pharmaceuticals International LtdWon by MACARTHYS LABORATORIES LIMITEDWon by Milpharm LimitedWon by Sun Pharma UK LimitedWon by Teva UK LimitedWon by Viatris UK Healthcare LimitedWon by Wockhardt UK LimitedWon by Zentiva Pharma UK LimitedWon by Fresenius Kabi Limited

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£52,447,296
Procedure
Open
Contract type
Framework agreement
SME suitable
Yes
Published
21 January 2026
Questions by
27 February 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£39,223,496
Award date
30 April 2026
Contract period
31 August 2026 → 31 May 2028
Winners
  • Accord UK Ltd
  • Amarox Limited
  • Ascend Laboratories
  • Aspire Pharma Limited
  • Baxter Healthcare Ltd
  • Brown and Burk UK Ltd
  • Cipla (EU) Limited
  • Colonis Pharma Ltd
  • Crescent Pharma Limited
  • Day Lewis Medical Ltd
  • Ennogen Healthcare International Limited
  • Fresenius Kabi Limited
  • G.L. Pharma UK Limited
  • Glenmark Pharmaceuticals (Europe) Ltd
  • Hikma Pharmaceuticals International Ltd
  • Jannsen-Cilag Limited
  • MACARTHYS LABORATORIES LIMITED
  • Milpharm Limited
  • Morningside Pharmaceuticals Ltd
  • Northumbria Pharma Limited
  • Selective Supplies Limited
  • Sun Pharma UK Limited
  • Teva UK Limited
  • Viatris UK Healthcare Limited
  • Wockhardt UK Limited
  • Zentiva Pharma UK Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    6 July 2026

  2. Contract

    1 May 2026

  3. Tender Update

    26 February 2026

  4. Tender Update

    30 January 2026

  5. Contract Notice

    30 January 2026

  6. Prior Information Notice

    21 January 2026

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.